These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3820601)

  • 1. [Basic evaluation of measurement of the serum level of squamous cell carcinoma-related antigen (SCC) and its value following irradiation of cancer of the uterine cervix].
    Obata Y; Tadokoro M; Kazato S; Nishi H; Ito M; Shibata H; Mizuno K; Kawamura N; Yamaguchi T; Yoshizumi T
    Gan No Rinsho; 1987 Jan; 33(1):60-4. PubMed ID: 3820601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC].
    Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R
    Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T; Nakayama Y; Nakamoto S; Kato S; Imai R; Nonaka T; Ishikawa H; Harashima K; Suzuki Y
    Cancer; 2003 Jun; 97(12):3114-20. PubMed ID: 12784349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
    Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
    Micke O; Prott FJ; Schäfer U; Tangerding S; Pötter R; Willich N
    Anticancer Res; 2000; 20(6D):5113-5. PubMed ID: 11326679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of serum squamous cell carcinoma-related antigen levels in penile cancer].
    Takahashi Y; Horie M; Isogai K; Takeuchi T; Shinoda I; Kuriyama M; Ban Y
    Hinyokika Kiyo; 1987 Mar; 33(3):396-9. PubMed ID: 3618407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
    Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
    Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
    Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
    Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
    Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
    Chan YM; Ng TY; Ngan HY; Wong LC
    Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
    Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
    Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
    Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements.
    Lozza L; Merola M; Fontanelli R; Stefanon B; Seregni E; Bombardieri E; De Palo G
    Anticancer Res; 1997; 17(1B):525-9. PubMed ID: 9066575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.